by Steven Ertelt
February 14, 2006
Livermore, CA (LifeNews.com) — Monty Patterson doesn’t want what happened to his daughter Holly to occur to any other women considering using the abortion drug RU 486. He says an announcement that the FDA is convening a panel of experts to study why his daughter and four other American women died from the abortion drug is long overdue.
In a statement provided to LifeNews.com, Patterson said the workshop, sponsored by the FDA and held at the CDC headquarters, "appears to be a public acknowledgment that [the abortion drugs] need further study as it pertains to women’s health and safety."
"The scientific and medical community can no longer ignore there are known specific properties of RU-486 that may predispose healthy young women to serious or lethal bacterial infections," he said.
"I look forward to a final outcome that will conclusively inform the medical community that RU-486 is not in the best interest of women as a choice for early medical abortion," Patterson added.
In September 2003, Holly’s boyfriend took her to Planned Parenthood.
Seven weeks pregnant, she was given the abortion drug mifepristone and also given misoprostol vaginal inserts to use two days later that would produce contractions and eventually expel the body of the dead baby.
After conducting an autopsy, the Alameda County Coroner’s office announced that Patterson died as a result of septic shock brought on by an incomplete abortion.
Frank Gentle, supervising coroner investigator, said "septic shock, due to endomyometritis (inflammation) due to therapeutic, drug-induced abortion," caused Patterson’s death. Endomyometritis is an inflammation of the mucous membrane lining of the uterus.
The inflammation set in several days after Patterson took the two-pill abortion drug combination.
In other words, "the abortion caused inflammation, which caused the shock, which caused her death," Gentle said.
Three other California women died after the RU 486 abortion drug caused the same problems. The FDA officials has asked scientists to explain why the drug is causing the infections that are resulting in deaths and injury to hundreds more women.
A Brown University researcher who studied the infections last year concluded that a rare bacteria collected in the women’s vaginal area and the infections became life-threatening before any of them knew a problem existed.
The problem has probably been exacerbated by abortion businesses like Planned Parenthood who are telling women to use the abortion drug vaginally, instead of orally as the FDA recommends.
Regardless of the outcome of the FDA conference, which will take place in May, Monty Patterson says he will continue to speak up for women.
"Women are paying the ultimate price with their health and lives. I will continue to speak for those who can’t speak for themselves," he said.